Stay updated on ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No substantive changes to trial details or site navigation are evident.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.1 released. No changes to the study content or primary information are evident from this update.SummaryDifference0.0%

- Check27 days agoChange DetectedAdds a 'Show glossary' option and updates metadata strings (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), replacing the previous forms (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). These changes are cosmetic and do not affect the study content or how the page is used.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedExpanded the list of study locations with new regional sections (e.g., Arizona, California, Ontario, Tokyo, Prague 1, Mazowian, SVK, etc.) and added a revision tag (v3.3.3); the HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check91 days agoChange DetectedRevision history shows an addition of Revision: v3.3.2 and a removal of Revision: v3.2.0; no other study information appears to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.